23 January 2025NewsEuropeTom Phillips
UKIPO’s new patent search tool marks ‘generational leap’
In an exclusive interview, the One IPO Search project lead explains how a change in mindset at the office helped ‘unlock the value’ of UK patent data.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Europe
18 July 2024 First patent filed using the new digital One IPO service | AI-powered internal tool to speed up the application process | Set for public launch in 2025 with a promise to “revolutionise” patent management.
Americas
10 December 2024 Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading pharma counsel.
Editor's picks
Editor's picks
Europe
18 July 2024 First patent filed using the new digital One IPO service | AI-powered internal tool to speed up the application process | Set for public launch in 2025 with a promise to “revolutionise” patent management.
Americas
10 December 2024 Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading pharma counsel.
Europe
18 July 2024 First patent filed using the new digital One IPO service | AI-powered internal tool to speed up the application process | Set for public launch in 2025 with a promise to “revolutionise” patent management.
Americas
10 December 2024 Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading pharma counsel.